美国 · 平台与数据 · The Motley Fool

AbbVie vs. Bristol Myers Squibb: Faster Growth or Steady Revenue?

来源：The Motley Fool · 美国 2 小时前

AbbVie's revenue lead has widened to $4 billion per quarter, but Bristol Myers shows surprising resilience despite slower growth.

在 The Motley Fool 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.fool.com)

推荐阅读

Time for a Micron mindset shift? Here’s how to navigate the new AI landscape.

Strategy Inc Variable Rate Series A Perpetual Stretch Preferred Stock (NASDAQ:STRC) Declares Dividend Increase - $0.04 Per Share

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Medical Properties earnings in focus as turnaround test looms

Walmart launches new membership deal, offers nearly $100 in savings

Nvidia’s Jensen Huang Sees 100GW AI Opportunity In Telecom Networks, With TMUS, NOK Already Making Moves